https://sudonull.com/moderna-s-personalized-mrna-vaccine-against-pancreatic-cancer-78-effect
Moderna released a personalized mRNA vaccine against pancreatic cancer: remission in 78% of patients over 18 months. FDA accelerated approval. Analysis of efficacy and risks.